Abstract: Provided is an influenza vaccine composition based on a novel ribonucleic acid having a dual function of serving as an immunity-boosting agent and capturing antigens.
Type:
Application
Filed:
February 18, 2022
Publication date:
June 9, 2022
Applicant:
NA VACCINE INSTITUTE
Inventors:
Mee Hyein KIM, Jin Soo SHIN, Dong Ho KIM, Eui Ho KIM, Myung Soo KANG, Ye Jin JANG